Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1B |
| 2 |
Merck
MRK
|
+$986M |
| 3 |
Abbott
ABT
|
+$969M |
| 4 |
NVIDIA
NVDA
|
+$967M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$814M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.46B |
| 2 |
Morgan Stanley
MS
|
+$910M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$909M |
| 4 |
Coca-Cola
KO
|
+$745M |
| 5 |
Arista Networks
ANET
|
+$692M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.51% |
| 2 | Technology | 19.42% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 10.08% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FOLD
551
DELISTED
Amicus Therapeutics
FOLD
| $98.2M | 0.02% |
7,820,296
+305,255
| +4% | +$3.62M |
|
552
iShares Russell 2000 Growth ETF
IWO
$14.6B
| $97.8M | 0.02% |
403,117
+190,092
| +89% | +$43.6M |
|
553
National Bank Holdings
NBHC
$1.92B
| $97.8M | 0.02% |
3,367,446
+384,742
| +13% | +$12M |
|
554
Republic Services
RSG
$64.5B
| $97.4M | 0.02% |
636,019
-10,658
| -2% | -$1.52M |
|
555
Gibraltar Industries
ROCK
$1.37B
| $97.3M | 0.02% |
1,546,520
-5,506
| -0.4% | -$298K |
|
556
Fabrinet
FN
$16.3B
| $96.8M | 0.02% |
745,468
-53,502
| -7% | -$5.71M |
|
557
Ormat Technologies
ORA
$6.02B
| $96.3M | 0.02% |
1,196,925
+744,845
| +165% | +$63.1M |
|
|
PGTI
558
DELISTED
PGT, Inc.
PGTI
| $96.3M | 0.02% |
3,303,527
-1,344,510
| -29% | -$35.4M |
|
|
ACH
559
Accendra Health
ACH
$261M
| $94.6M | 0.02% |
4,970,148
+150,427
| +3% | +$2.68M |
|
560
CenterPoint Energy
CNP
$27.6B
| $94.3M | 0.02% |
3,236,637
+144,381
| +5% | +$4.27M |
|
561
Capital One
COF
$134B
| $94.1M | 0.02% |
860,576
+480,387
| +126% | +$48.1M |
|
|
PDCE
562
DELISTED
PDC Energy, Inc.
PDCE
| $93.7M | 0.02% |
1,316,884
-2,566,620
| -66% | -$173M |
|
563
Cactus
WHD
$5.12B
| $92.9M | 0.02% |
2,196,354
-430,030
| -16% | -$16.8M |
|
564
Boeing
BA
$185B
| $92.9M | 0.02% |
439,982
-24,129
| -5% | -$5.01M |
|
565
American Financial Group
AFG
$11.8B
| $92.9M | 0.02% |
782,201
+105,779
| +16% | +$12.5M |
|
566
NiSource
NI
$21.3B
| $92.8M | 0.02% |
3,394,659
-23,984
| -0.7% | -$666K |
|
|
VRE
567
DELISTED
Veris Residential
VRE
| $92.3M | 0.02% |
5,750,894
+1,708,791
| +42% | +$27.6M |
|
568
Monro
MNRO
$399M
| $92M | 0.02% |
2,263,554
+121,007
| +6% | +$5.46M |
|
569
Genmab
GMAB
$17.6B
| $91.9M | 0.02% |
2,417,137
-3,783
| -0.2% | -$151K |
|
570
argenx
ARGX
$52B
| $91.2M | 0.02% |
234,055
-24,221
| -9% | -$9.53M |
|
571
Douglas Emmett
DEI
$1.99B
| $91.2M | 0.02% |
7,254,252
+46,939
| +0.7% | +$567K |
|
|
VRNA
572
DELISTED
Verona Pharma
VRNA
| $91M | 0.02% |
4,303,303
+1,011,830
| +31% | +$21.6M |
|
|
DO
573
DELISTED
Diamond Offshore Drilling, Inc.
DO
| $91M | 0.02% |
6,387,247
-1,159,726
| -15% | -$13.7M |
|
574
UMB Financial
UMBF
$11.2B
| $90.8M | 0.02% |
1,491,071
+472,023
| +46% | +$28.2M |
|
|
ERF
575
DELISTED
Enerplus Corporation
ERF
| $89.9M | 0.02% |
6,201,941
+305,073
| +5% | +$4.45M |
|
Similar funds
Wellington Management Group's Q2 2023 Portfolio in Review
As of Q2 2023, Wellington Management Group held 2,099 positions worth $527B, up 4.5% from $505B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Wellington Management Group's Q2 2023 filing shows 119 new, 718 increased, 815 reduced and 304 closed positions. Its largest new stake was Kenvue: 10,602,707 shares worth $280M. The largest sale was Eli Lilly, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Financials.
- Wellington Management Group's largest Q2 2023 buy was Kenvue: 10,602,707 shares worth $280M.
- Wellington Management Group added most to Gilead Sciences in Q2 2023, an estimated $1B increase.
- Wellington Management Group's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $2.46B.
- Wellington Management Group fully exited Syneos Health, Inc. Class A Common Stock in Q2 2023, selling an estimated $267M.
- Wellington Management Group's ten largest holdings make up 20% of its $527B portfolio in Q2 2023.
- Wellington Management Group opened 119 new positions and closed 304 in Q2 2023.
- Wellington Management Group's portfolio value rose 4.5% quarter-over-quarter to $527B.
Based on Wellington Management Group's 13F filing for Q2 2023, filed 14 Aug 2023.